Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Combination
medical devices
Barrier systems
Planetary protection
Environmental
monitoring
VOLUME 22, NO. 1, JANUARY 2008
Combination
medical devices
Barrier systems
Planetary protection
Environmental
monitoring
Combination
medical devices
Barrier systems
Planetary protection
Environmental
monitoring
Combination
medical devices
Barrier systems
Planetary protection
Environmental
monitoring
Contents Zoom In Zoom Out For navigation instructions please click here Search Issue Next Page
Contents Zoom In Zoom Out For navigation instructions please click here Search Issue Next Page
WHEN THE BIGGEST RISK IS MEASURED IN MICRONS, you need to know someones paying attention
to the smallest detail. Thats why our scientists and engineers created DuPont
Tyvek
IsoClean
IsoClean
Suprel
READY.
C
o
p
y
r
i
g
h
t
2
0
0
7
D
u
P
o
n
t
.
A
l
l
r
i
g
h
t
s
r
e
s
e
r
v
e
d
.
T
h
e
D
u
P
o
n
t
O
v
a
l
L
o
g
o
,
D
u
P
o
n
t
T
M
,
T
y
v
e
k
I
s
o
C
l
e
a
n
T
M
a
n
d
S
u
p
r
e
l
L
S
a
r
e
r
e
g
i
s
t
e
r
e
d
t
r
a
d
e
m
a
r
k
s
o
r
t
r
a
d
e
m
a
r
k
s
o
f
E
.
I
.
d
u
P
o
n
t
d
e
N
e
m
o
u
r
s
a
n
d
C
o
m
p
a
n
y
o
r
i
t
s
a
f
l
i
a
t
e
s
.
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
________________________
Since 1993, our patented non-aspirating
DECON-AHOL WFI Sterile Alcohol has
offered the highest quality sterile alcohol,
whether it is used upright or inverted, to
assure 100% evacuation at a 10
-6
Sterility
Assurance Level.
USP LAL tested and filtered at 0.2 microns
Sterility shelf-life is validated for 3 years
Double bagged packaged and gamma
irradiated
Reduces pyrogens into the aseptic area
Eliminates in-house manufacturing
Completely documented, traceable
and validated as sterile
15 Lee Boulevard
Malvern, PA 19355-1234 USA
(610) 644-8335 Fax (610) 644-8336
TOLL FREE: (888) 478-3745
Sterile USP 70% Isopropyl Alcohol
www.sterile.com
Veltek Assoc.
Made with USP Water for Injection
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
NOW IN ITS 10
TH
YEAR
The 10th annual international trade fair for cleanroom design, hygiene and contamination control.
COST AND ENERGY EFFICIENT CONTAMINATION CONTROL
Owned and produced by:
R
Flagship Media Sponsor:
www.cleanrooms-europe.com
EXHIBITING
For more information about exhibiting and sponsorship
opportunities at CleanRooms Europe 2008 please contact:
USA
Barbara Kovalchek
National Sales Manager
(e): barbarak@pennwell.com
(t): +1 603 891 9296
Europe and Rest of the World
Sabine Staiger
Exhibition Sales Manager
(e): sabines@pennwell.com
(t): +49 7171 104 67 14
(f): +49 7171 104 67 20
CLEANROOMS EUROPE 2008
CONFERENCE AND EXHIBITION
11-13 March 2008
Hall C2, Neue Messe Stuttgart, Stuttgart, Germany
CONFERENCE SCHEDULE
Tuesday 11 March 2008
Solar Technology Manufacturing
Hospital Infection Control
Wednesday 12 March 2008
Advanced Life Science Manufacturing
Ultrapure Semiconductor Processing & Molecular
Contamination Control
Thursday 13 March 2008
Automotive Technical Cleaning & Sauberraum
Standards Activities & Energy Saving Design &
Operation Techniques
PLUS
Tuesday 11 March 2008
Contamination Control Essentials full day workshop
Offered for the rst time in Stuttgart and presented by
internationally acknowledged contamination control expert
instructor, Dr Hans Schicht.
* Earlybird conference discount cut-off date is 25 January 2008.
Free exhibition entry cut-off date is 3 March 2008.
REGISTER NOW AT: WWW.CLEANROOMS-EUROPE.COM
To gain earlybird conference delegate rates and FREE entry to the
extensive CleanRooms Europe 2008 exhibition*.
Celebrating its 10th anniversary staging, CleanRooms Europe 2008 in Stuttgart, Germany offers a
dynamically expanded conference programme that turns a highly relevant and timely energy cost
reduction spotlight on multi-discipline contamination control.
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
__________________________
Combination device manufacturers need to consider the biocompatibility
and restrictions of all components to achieve a successful product design.
Shown here is STMicroelectronics In-Check lab-on-chip device, which
combines a MEMS microfuidic chip with a DNA microarray for medical
diagnostics and microbial detection. Photo courtesy of STMicroelectronics.
contents
16 Plan ahead for combo
device success
By Sarah Fister Gale
24 Using RABS and isolators in
pharmaceutical applications
By Jack Lysfjord, Lysfjord Consulting LLC
28 New detection methods reinforce
protocols for planetary protection
By Patrick Hogue, Johns Hopkins University,
Applied Physics Laboratory
32 Planning and installing an
environmental monitoring system
By Mark Hallworth and Edward Applen,
Particle Measuring Systems
16
Volume 22, Number 1, January 2008
CleanRooms magazine (ISSN 1043-8017) is published monthly, 12 issues per year, by PennWell Corporation, 1421 South Sheridan Rd., Tulsa, OK 74112. Entire contents copyright 2008. No portion of this publication may
be reproduced in any form without written permission of the publisher. Views expressed by the bylined contributors should not be construed as refecting the opinion of this publication. Every precaution is taken to ensure the
accuracy of the information that is published. The publisher cannot accept responsibility of the accuracy of the information supplied. Publication of product/service information should not be deemed as a recommendation by
the publisher.
Editorial Contributions: CleanRooms accepts manuscripts from the contamination control industry. Contact the Editor for Editorial Guidelines. Product/Service Information: Should be submitted in accordance with
guidelines available from the Editor. Editorial closing date is two months prior to month of publication.
European Subscriptions: PennWell European Journal Service, P.O. Box 4456, London SW12 8AX, United Kingdom. Change of Address: Send old label as well as new address to: Circulation Manager, CleanRooms, Omeda
Communications, PO Box 3282, Northbrook, IL 60065-9592.
Authorization to photocopy items for internal or personal use, or the internal or personal use of specifc clients, is granted by CleanRooms, ISSN 1043-8017, provided that the appropriate fee is paid directly to Copyright Clearance
Center, 222 Rosewood Drive, Danvers, MA 01923 USA, 978-750-8400. Prior to photocopying items for educational classroom use, please contact Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923 USA
978-750-8400. For further information check CCC Online at the following address: http://www.copyright.com/
A controlled circulation publication, CleanRooms is distributed without charge to qualifed subscribers. Nonqualifed Subscription Rates: U.S. $95 per year; U.S. 2-year $152; Canada/Mexico $127 per year, $202 2-year;
International Air $159 one year, $254 2-year. Single copies $12.00 (US), $17 (Intl Surface), $17 (Intl Air). Buyers Guide Issues: $58 (US), $69 (Intl Surface), $81(Intl Air). All rates are payable in U.S. funds. Periodicals
Postage Paid at Tulsa, OK 74112 and at Additional Mailing Offces. Return Undeliverable Canadian Addresses to: P.O. Box 122, Niagara Falls, Ontario CANADA L2E 6S4.
POSTMASTER: Send address changes to CleanRooms, Omeda Communications, PO Box 3282, Northbrook, IL 60065-9592.
Printed in the U.S.A. GST No. 126813153
Publications Mail Agreement Number 40052420
Features
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
E D I T O R I A L A D V I S O R Y B O A R D
Frank X. Austin
Clean Air Technology
C.W. Berndt
C.W. Berndt Associates
David Brande
NNE US Inc.
Roger Diener
Analog Devices
Anne Marie Dixon
Cleanroom Management Associates
Dr. Johann Dorner
Fraunhofer Institute Manufacturing
Engineering & Automation
Gordan M. Ely
Nelson Laboratories, Inc.
Jan Eudy
Cintas Corporation
Adam Giandomenico
Adams Instruments
Thomas E. Hansz AIA
Facilities Planning & Resources
Allyson Hartzell
Exponent Failure Analysis Associates
Eric Kastango
Clinical IQ
Elaine Kopis-Sartain
Steris Corporation
Dr. Sowmya Krishnan
Ultra Clean Technology
Richard Matthews
Filtration Technology
Kathy Miscioscio
Cleanroom Consultant
Dr. Richard Pavlotsky, P.E.
Greene Engineers
Henry D. Rahe
Contain-Tech
Michael Rataj
Aramark Cleanroom Services
David J. Ruede
Entegris, Inc.
Scott Salton
Lighthouse Worldwide Solutions
Dr. Hans H. Schicht
Schicht AG
Dr. R. Vijayakumar
Aerl, LLC
Jim Wagner
Controlled Environments Consulting
Top news
8 Experts cite missed opportunity in NIH
risk assessment of BSL-4 lab
11 Survey says: PPE compliance remains
a top workplace concern
11 FDA advisors declare FDA science and
mission at risk
Columns
14 Setting the standard
IEST marches on to nanotech beat
36 Product spotlight
Cleanroom garments
40 New products
48 Calendar
JOHN HAYSTEAD Publisher/Editor/jhaystead@pennwell.com
CARRIE MEADOWS Managing Editor/carriem@pennwell.com
SARAH FISTER GALE Correspondent (Chicago, IL)
BRUCE FLICKINGER Correspondent (Princeton Junction, NJ)
HANK HOGAN Correspondent (Austin, TX)
GEORGE MILLER Correspondent (Littleton, MA)
JASON T. BLAIR Manager, Magazine Presentation
CLARK BELL Presentation Editor
RAE LYNN COOPER Production Manager
ILLUSTRATION TEAM Kermit Mulkins, Kay Wayne, Mike Reeder
KIMBERLEE SMITH Ad Traffc Manager
MICHELLE BLAKE Circulation Manager
KRISTEN JONES Marketing Communications Manager
KATRINA FRAZER CleanRooms Show Management
Editorial /Executive Offces 98 Spit Brook Road
Nashua, N.H. 03062-5737
Phone: (603) 891-0123
Fax: (603) 891-9200
www.cleanrooms.com
LETTERS TO THE EDITOR ARE WELCOME. Please include your postal address
(even on e-mail) and a telephone number. Letters will be edited for length and style.
CLEANROOMS ON THE INTERNET. Visit our Internet site
(www.cleanrooms.com) for news, features and product information.
BUYERS GUIDE INQUIRIES should be directed to
Linda Smith-Quinn at (603) 891-9370 or linda@pennwell.com.
SUBSCRIPTIONS: To order or renew, or to change your address, or for back issues, contact circulation
department at 847-559-7500 or www.omeda.com/custsrv/crm. We make portions of our subscriber
list available to carefully screened companies that offer products and services that may be important
for your work. If you do not want to receive those offers and/or information, please let us know by
contacting us at List Services, CleanRooms, 98 Spit Brook Road, Nashua, N.H. 03062.
RETURN UNDELIVERABLE CANADIAN ADDRESSES TO: P.O. BOX 122, NIAGARA FALLS, ON L2E 6S4.
TO SUBSCRIBE ONLINE, GO TO WWW.CR-SUBSCRIBE.COM.
Technology Group
CHRISTINE SHAW Senior Vice President & Publishing Director
Advanced Technology Division
GLORIA S. ADAMS Director of Audience Development
ATD Publishing Departments
JUDITH M. SIMERS ATD Buyers Guide Director
SANDY TAYLOR Buyers Guide Database Administrator
Corporate Offcers
FRANK T. LAUINGER Chairman
ROBERT F. BIOLCHINI President and CEO, PennWell
MARK C. WILMOTH Chief Financial Offcer
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
__________
Most cleanroom suppliers
conform to standards.
Only one company sets them.
More than just a supplier. Customized solutions
to t you.
Any company can be a supplier. But what you really need is
a partner. One thats devoted to the highest level of service.
ARAMARK stands alone in our complete dedication to
excellence. Thats why we have Quality Assurance Managers
at each processing facility, each with a complete staff of QA
technicians. So you can rest assured that your cleanroom
garments meet our strict standards. With ARAMARK, you
can feel condent you have the right solution.
1-800-759-0102
www.ARAMARK-Cleanroom.com
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
from the editor
Changes
During this election season, weve all heard a lot of talk about change. Its the
favorite buzzword of just about every candidates campaign and seems to impart
some magical meaning of its own. The problem is that no one is at all clear as to
what kind of change they are advocating, planning to implementor voting for, for
that matter. Of course, the truth is that change is simply thatchange. And it can be
good or bad depending on what it actually involves and where you sit.
Here at CleanRooms, were experiencing change as wellthe real kind, the
kind you can identify. But what I want to talk about most is much more important
than thatthe things that arent changing, and wont.
The most obvious change here at CleanRooms is our Publisher. After many
years of dedicated service, Jim Enos will now be putting his talents and energy into a
new career. It will certainly be a personal change for me not to have his tremendous
enthusiasm, advice, and leadership but, at the same time, the total commitment to
the contamination control industry and to the community of professionals that make
it up, exemplied by CleanRooms under Jims direction, will not change in any way,
shape or form. In fact, I am extremely proud to have been passed the responsibility
of making sure of that.
Since rst being introduced to the contamination control community some
twelve years ago, I have never lost my appreciation for its vitality, dedication to
excellence, and innovative spirit. Nor have I forgotten the fact that were also a tight-
knit group very much based on personal relationships and trust as well as shared
experiences, challenges, and objectives. This also will not change.
CleanRooms has always taken a leadership role in the industry, seeking out
new technology developments and innovative implementations for our readers and
identifying and targeting emerging business opportunities for our advertisers. This
will not change either.
Going forward CleanRooms will also not change our philosophy of welcoming,
listening to, and learning from the feedback and suggestions of you, our readers. This
will always be a cornerstone of our business strategy.
We have a great many new and exciting plans for the year ahead and beyond.
I look forward to both bringing them to you and working with you on them. In fact,
this brings me to one nal thing that will not changehow much fun I have being
a part of this great industry.
Im John Haystead and I not only approved this message, I wrote it myself.
John Haystead,
Publisher & Editor
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
Choose From More Than Seventeen Cleaning
And Disinfecting Systems
We are the worlds leading manufacturer, supplying a wide range of multi-bucket cleaning
systems engineered to capture and isolate contaminants. Our TruCLEAN systems are designed to
deliver uniform application of solutions to walls, floors and ceilings. Easy operator adaptability.
Reliable performance. Consistent results. GUARANTEED.
All TruCLEAN Systems compatible with Gamma,
ETO and Autoclave Sterilization.
FREE
PERFEX CORPORATION
Experts in Clean Systems for Controlled Environments
800-848-8483 USA & Canada 315-826-3600 Fax: 315-826-7471
E-MAIL: perfex@ntcnet.com WEBSITE: www.perfexonline.com
CLEAN & DISINFECT
FLOORS, WALLS &CEILINGS
PROFESSIONAL REFERENCE GUIDE
CD ROM AND VIDEO ALSO AVAILABLE
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
8 C L E A N R O O MS J A N U A R Y 2 0 0 8
news
w w w . c l e a n r o o m s . c o m
Summary of recommended biosafety levels for infectious agents
BSL Agents Practices Primary barriers and Facilities
safety equipment (secondary barriers)
1 Not known to consistently Standard microbiological None required Laboratory bench and
cause diseases in healthy practices sink required
adults
2 Agents associated with BSL-1 practice plus: Primary barriers: BSL-1 plus:
human disease Limited access Class I or II BSCs or other Autoclave available
Routes of transmission Biohazard warning signs physical containment devices
include percutaneous injury, Sharps precautions used for all manipulations
ingestion, mucous membrane Biosafety manual defning of agents that cause
exposure any needed waste splashes or aerosols of
decontamination or medical infectious materials
surveillance policies Personal protective
equipment (PPE):
Laboratory coats, gloves, face
protection as needed
3 Indigenous or exotic BSL-2 practice plus: Primary barriers: BSL-2 plus:
agents with potential for Controlled access Class I or II BSCs or Physical separation from
aerosol transmission Decontamination of other physical access corridors
Disease may have serious all waste containment devices Self-closing double-door access
or lethal consequences Decontamination of used for all open Exhaust air not recirculated
laboratory clothing before manipulation of agents Negative airfow into laboratory
laundering PPE:
Baseline serum Protective laboratory clothing,
gloves, respiratory protection
as needed
4 Dangerous/exotic agents BSL-3 practices plus: Primary barriers: BSL-3 plus:
which pose high risk of life- Clothing change before All procedures conducted in Separate building or isolated
threatening disease entering Class III BSCs or Class I zone
Aerosol-transmitted Shower on exit or II BSCs in combination Dedicated supply and exhaust,
laboratory infections have All material decontaminated with full-body, air-supplied, vacuum, and decontamination
occurred; or related agents on exit from facility positive-pressure personnel systems
with unknown risk of suit Other requirements outlined in
transmission the text
Experts cite missed opportunity in NIH risk
assessment of BSL-4 lab
By George Miller
A National Research Council (NRC) committee
of experts provided a boost to neighbors
opposing construction of a biocontainment
research lab at the Boston University Medical
Center by declaring in late November that a
draft environmental impact report concerning
the facility is not sound and credible.
The declaration compounds the complex-
ity of a labyrinthine approval process whose
players span neighborhood activists to ofcials
at the city, state, and federal levels, all result-
ing from Project Bioshield legislation enacted
following the 9/11 and anthrax letter attacks
of 2001. The NRC experts viewed the report as
an opportunity to quell fears about the safety
of biocontainment facilities.
The National Institutes of Health (NIH)
is now implementing a construction pro-
gram that will complete four new BSL-4 fa-
cilitiesincluding the $200 million BU lab,
Source: Biosafety in Microbiological and Biomedical Laboratories (BMBL), 5th Edition, U.S. Department of Health and Human Services, Centers for Disease
Control and Prevention and National Institutes of Health, February 2007.
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
_________________
news
J A N U A R Y 2 0 0 8 C L E A N R O O MS 9 w w w . c l e a n r o o m s . c o m
now 70 percent completeas well as 14 BSL-3
facilities within the next few years [see Lab
Biosafety Hearings Conjure Cold War Fears,
CleanRooms, December 2007, p.7. Differences
in biosafety level protocols are shown in the ac-
companying table].
Neighbors who oppose the facility question
BUs ability to protect their Boston neighborhood
while running a BSL-4 facility, given the
institutions track record: At an existing BSL-2
lab in 2004, for example, researchers violated
safety procedures and became infected with
tularemia; at an advanced biomedical research
building in early 2007, a medical waste re led
to the buildings evacuation.
Chief among the NRC expert committees
concerns is the lack of inclusion of highly
infectious agents in the NIH draft assessment,
and the subsequent lack of a credible worst-
case scenario. A more acceptable analysis
would have included agents that are readily
transmissible and would have demonstrated
that the modeling approach used recognizes
biological complexities, reecting what is
known about disease outbreaks and being
appropriately sensitive to population density,
according to an NRC statement.
In addition, the draft assessment contains
too little information to compare the risks as-
sociated with alternative BU campus locations
in suburban (Tyngsborough, MA) and rural
(Peterborough, NH) settings for the laboratory.
Considering pathogens that spread more eas-
ily would improve analyses of how risks vary
depending on location, the committee said. It
was also dissatised with the draft assessments
consideration of environmental justice issues
and how the biocontainment facility could af-
fect the inner-city population in particular.
Missed opportunity
Expert committee member Gary Smith, chief
for epidemiology and public health at the
University of Pennsylvania School of Veterinary
Medicine, said that, given the type of model
that NIH researchers used in preparing the
draft statement, this seems to have been a
missed opportunity, especially when the three
locations were considered. The NIH draft could
have presented a more rened analysis of the
risks presented by a facility like BUs, he said,
and evaluated comprehensively the impact of a
worst-case scenario event on public health and
safety. Doing so might have provided greater
assurances for the neighbors and might also
have been viewed as relevant to assessments
continued on page 10
The NRC experts viewed
the report as an opportunity to
quell fears about the safety of
biocontainment facilities.
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
__________________
__________________________________________
The BU Medical Center BSL-4 biocontainment
lab facility, now about 70 percent complete, is
part of the Biosquare II project on Albany Street
in Boston. Image courtesy of Boston University
Medical Center.
10 C L E A N R O O MS J A N U A R Y 2 0 0 8
news
w w w . c l e a n r o o m s . c o m
BSL-4 continued from page 9
for other biocontainment facilities.
The experts question whether the NIH fully
exploited the agent-based model used in the
analysis. The committee writes that such models
are particularly good at revealing the inuence
of heterogeneities in the host population.
Relevant examples, with respect to comparing
the three locations, include host characteristics
that may affect susceptibility and case fatality
rates. But there was no reference to expected or
plausible differences on transmission probability
for those at special risk (the very young, the very
old, those with preexisting conditions, and those
with compromised immune systems), according
to the report.
In addition, NIH appears to have made the
assumption in its model that each person has
10 contacts per day, regardless of the population
density of the location. This assumption about
the number of contacts further reduces the
opportunity for transmission and effectively
eliminates one of the most important
differences between locations, the report said.
Environmental justice concerns
NRC expert committee member Gigi Kwik
Gronvall, assistant professor of medicine
and senior associate at the University of
Pittsburgh Medical Centers Biosecurity Center
in Baltimore, added during the NRC press
conference that the draft NIH document also
took into account neither the health status of
the population, nor the Boston neighborhoods
status as a U.S. Environmental Protection
Agency environmental justice community. We
didnt see accommodations for public health
access in the report, she said. We dont know
if it makes a difference. We just want to know
that it was addressed.
The neighborhood is acknowledged to
have among the highest rates of HIV infections
in Boston, as well as a high rate of intravenous
drug use and correspondingly high incidence
of hepatitis C.
One of several things that affects how
diseased one becomes during an outbreak
is health status [of residents], said expert
committee member Smith. That status
varies with age distribution, pregnancy rate,
and proportion of immunocompromised
individuals, among other factors.
The experts make clear in both their
report and cover letter that their conclusions
concern only the scientic adequacy of
the NIH draft supplementary risk analysis,
and not the previously submitted, original
risk assessment and site suitability analysis
document submitted by NIH as a standard part
of the NEPA process.
It is important to recognize, the experts
write, that these conclusions are based solely
on the committees technical review of the
[NIH draft], and thus they should not be viewed
as statements about the risks of proposed
biocontainment facilities in Boston, or in cities
more generally. The Committee acknowledges
the need for biocontainment laboratories in
the United States, including BSL-4 laboratories,
and recognizes that BSL-4 facilities are being
operated in other major urban areas.
The NIH, while acknowledging via e-mail
correspondence that the NRC has raised
important concerns, makes no apologies
for the document it drafted: NIH followed
the NEPA procedures in preparing a nal
environmental impact statement and in issuing
a record of decision on the BU lab, according
to a statement issued after the NRC report was
released in late November.
NIH said it will continue to follow the
standard NEPA process and will consider and
respond to all comments received, including
those of the NRC experts.
For its part, the Boston University Medical
Center said in a statement, We recognize
that the NRC report states concerns regarding
the NIH methodology and analysis and are
condent that the NIH will address those issues
in its nal report. In the meantime, we stand
ready to provide whatever information we can
in order to respond to questions and concerns,
and to document that the South End site is as
safe as or safer than alternative locations.
P A R T I C L E S
compiled by Carrie Meadows
Gerbig Engineering introduces
new cleanroom construction
feature
Minnesota-based Gerbig Engineering, a
specialist in the design, build, installation,
and certifcation of cleanrooms, now offers
a raceway that is integrated into the framing
system of its cleanroom constructions.
The raceway allows wiring, cabling, and
plumbing to be threaded throughout the
cleanroom and remain totally hidden.
The system will work for both hardwall
and softwall systems, and for portable or
stationary cleanrooms. Existing AireCell
Cleanrooms can be retroftted with this
raceway system.
New England Peptide opens
instrumentation lab
New England Peptide, LLC (NEP), a company
that designs and produces custom peptides
and polyclonal antibodies for drug and
vaccine discovery organizations, has
opened a new production instrumentation
laboratory at its Massachusetts facility. NEPs
engineering staff will use the dedicated lab
to develop new instrumentation, qualify
newly acquired production equipment, and
effciently bring instrumentation offine for
maintenance.
David Savage lands
at Ultra Clean
Ultra Clean Technology, a developer and
supplier of critical subsystems for the
semiconductor capital equipment industry,
announced the appointment of David
Savage as president and CEO, effective
Jan. 8. Leonard Mezhvinsky retired from the
position of president as of Dec. 31. Savage
brings to Ultra Clean more than 20 years
of executive experience. Before joining
UCT, Savage was CEO of Litel Instruments,
Inc., a semiconductor optical metrology
business. He has also served as president
of the Electronics Division of Meggitt USA,
Inc., and as CEO at DigMedia, a media
delivery business focused on broadband
service providers.
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
__________________
1800 Ocean Avenue Ronkonkoma, NY 11779-6532
1-(631) 588-7000 Fax: 1-(631) 588-7863
www.knfcorporation.com sales@knfcorporation.com
KNF Clean Room Products has gone
beyond clean to Ultraclean Film
for your
packaging needs to preserve all the care
youve taken in manufacturing your
product. Our unique bags, sheets, roll
stock, and breather bags are manufactured
in a Class 100 clean room under the most
stringent quality control conditions, and
are available in a variety of materials
(LDPE, HDPE, Aclar, FEP, Nylon,
Polypropylene, Multilaminate, etc.).
Thicknesses, sizes and configurations,
both standard and custom, are available to
your exact specifications. From aerospace
to electronics, from pharmaceuticals to
food, from wafer fab to precision parts
manufacture... no one safeguards the
cleanliness of your product like KNF Clean
Room Products.
KNF CLEAN ROOM PRODUCTS Corporation
How KNF Clean Room Products
Ultraclean Film
assures
absolute integrity of
your product.
Call today to find out how we can help with
all your clean packaging requirements.
news
J A N U A R Y 2 0 0 8 C L E A N R O O MS 11 w w w . c l e a n r o o m s . c o m
Survey says: PPE compliance remains a top workplace concern
For the second year in a row, a survey of safety
professionals has found that non-compliance
with personal protective equipment (PPE) proto-
cols continues to be an issue in the workplace.
Eighty-seven percent of respondents said
they had observed workers failing to wear PPE
when they should have been, according to a
survey of attendees at the 2007 National Safety
Council (NSC) Congress, conducted by Kimberly-
Clark Professional, last fall. Eighty-ve percent
of safety professionals answered yes to the same
question in a survey undertaken by Kimberly-
Clark Professional at the 2006 NSC Congress.
Despite the undisputed need for PPE when
undertaking hazardous tasks, people continue to
risk bodily harm by failing to protect themselves,
said Randy Kates, general manager of the safety
business for Kimberly-Clark Professional. In
this survey, we not only asked why people did not
comply with PPE protocols but what could be
done to alter these behaviors.
The main reason 62 percent of respondents
gave for noncompliance is that PPE was
uncomfortable. This was followed by workers
thinking PPE was not necessary for the task, was
too hot, t poorly, or was unattractive looking.
So its no surprise that when asked what could
be done to improve the PPE they were currently
purchasing, 75 percent of survey respondents said
they would make it more comfortable.
The survey also investigated the effect of
environmental considerations on purchasing
PPE and other personal safety products. Ninety-
four percent of respondents said environmental
considerations and reducing the impact on the
environment were important to them. Sixty-
four percent ranked these as very important,
while 20 percent described them as somewhat
important. Ten percent said environmental
factors were increasingly important now, as
compared to a few years ago.
The survey also asked respondents to choose
between two types of industrial wiping products: a
recycled cloth towel that is laundered and reused,
releasing chemicals and metal contaminants
in the wastewater of industrial laundries, or
a disposable paper or paper/polymer wiping
product that is discarded into a landll after
use. Fifty-six percent said they would choose the
disposable wiper. Twenty-seven percent selected
the laundered towel. Seventeen percent said they
did not know which product they would pick.
Survey questionnaires were lled out by
197 safety professionals who reported being re-
spon-sible for purchasing, selecting, or inuenc-
ing the purchase or selection of, or compliance
with, PPE. Respondents were from elds such as
industrial manufacturing, construction, hazmat,
emergency response, clean manufacturing, labo-
ratories and science, health care, transportation,
law enforcement, and government. For full sur-
vey results, visit http://www.kcprofessional.com/
us/mkt/nscpressrelease.
FDA advisors declare
FDA science and
mission at risk
According to a subcommittee of the U.S. Food
and Drug Administrations Science Board,
the nations food supply is at risk, as are the
regulatory systems that oversee the nations
drug and device supplies. In a report presented
in December, the subcommittee attributed the
deciencies to increased demands on FDA and
resources that have not increased in proportion
to those demands. Committee members conclude
that this imbalance is imposing a signicant
risk to the integrity of the food, drug, cosmetic,
and device regulatory system, and hence the
safety of the public.
The result of a year-long review by a dis-
tinguished panel of experts, the subcommittees
300-page report concludes that the state of FDAs
scientic and regulatory programs could not be
separated from the lack of resources. It urged
funds to support the agencys scientic base,
hire a broadly capable scientic workforce, and
build a sophisticated, modern information tech-
nology infrastructure.
Upon the reports release, Don Kennedy,
PhD, a former FDA commissioner and editor-
FDA continued on page 13
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
_____________
__________________
Owned and Produced by: Flagship Media Sponsor:
Meet the executives making the buying decisions for your
products at the leading nanotechnology andMEMS event.
The Small Tech Conference & Expo is the one event
focused on the most important nanotechnology and
MEMS products that are having an impact on the market
today. Attracting hundreds of key decision makers from
aroundthe world, the Small TechConference &Expo is the
place to learn about new technologies and intelligent
engineeringapplications, exchangeinformation, anddevelop
the strategies that will drive innovation in nanotechnology
and MEMS.
www.SmallTech.com
Exhibit Sales & Sponsorship
Contact Jeff Gallagher
Phone: +1-603-891-9147
Email: jeffg@pennwell.com
November 1012, 2008
Santa Clara Convention Center
Santa Clara, CA
NETWORK.
CONNECT.
INNOVATE.
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
Since 1982, Clean Rooms
International has been
designing and
fabricating
equipment
and cleanroom
systems for
a wide range
of workspace
environments.
Our products
have been installed
in health care, research,
pharmaceutical and medical
device facilities around the world.
SAM
Fan Filter Units
feature energy efcient
EBM motors, solid-state
variable speed control
with RFI suppression
and equipped with either
HEPA or ULPA lters.
Models are UL listed and
are compatible with our CRI Airlink Control System.
We offer a comprehensive
line of Clean Bench and
Workstation models for
controlling airborne con-
tamination within a small
space. These units provide
practical and economical
work-space environments
for use in pharmaceutical
or hospital applications and
isolating a manufacturing process or for conducting
research.
Matching the best products and service in the
industry with on-time delivery and technical support.
Well Help You
Provide A Clean
Environment
Phone 616.452.8700
s a l e s @c l e a nr ooms i nt . c om
www. c l e a nr ooms i nt . c om
Made i n t he USA Si nc e 1982
Designing Flexible Solutions
J A N U A R Y 2 0 0 8 C L E A N R O O MS 13 w w w . c l e a n r o o m s . c o m
news
P A R T I C L E S
compiled by Carrie Meadows
USP <797> revisions now available
The U.S. Pharmacopeia has posted the Revision Bulletin containing
changes to General Chapter Pharmaceutical CompoundingSterile
Preparations <797> on its web site at http://www.usp.org/USPNF/
pf/generalChapter797.html. The revisions will become offcial
on June 1, 2008, and will be included in USP 32NF 27 and the
upcoming second edition of Pharmacists Pharmacopeia. USP says
that the revised standards are being published online to give the
compounding community time to implement changes before the
offcial date.
BASF completes European electronic materials center
The Electronic Materials Center Europe at BASFs Ludwigshafen,
Germany site is complete after approximately 15 months under
construction. The production plant will provide process chemicals for
the semiconductor industry throughout Europe. The center includes
state-of-the-art purifcation facilities as well as cleanroom flling
stations to ensure high purity and consistent quality of the products.
After completion of the qualifcation activities at the end of 2007,
routine production was scheduled to commence on Jan. 1.
Microtest expands facilities and services
Microtest, a provider of testing services and contract manufacturing
for the medical device, pharmaceutical, and biotechnology industries,
has doubled the size of its medical device/pharmaceutical stability
storage capabilities, as well as signifcantly expanding its medical
device packaging laboratory and its GMP pharma fll/fnish contract
manufacturing services at its Agawam, MA-based headquarters.
Package validation is needed to support our medical device clients.
Were also dedicating additional new space to our growing product
stability testing laboratories as well as our GMP drug manufacturing
services, says president and scientifc director Steve Richter.
FDA continued from page 11
in-chief of Science magazine, and also a member of the FDA Alliance, an
advocacy organization formed in 2006, commented that FDA cant improve
its science, prepare for the future, or protect American consumers without
signicant additional resources. Congress is negotiating FDAs FY 2008
[current year] budget right now and can start to x this critical problem.
The cry for more FDA resources was echoed by the Coalition for a
Stronger FDA, which comprises patient groups, non-prot organizations,
consumer and public health advocates, and innovative companies
with the goal of working alongside policymakers to bolster and preserve
public condence in FDA. Over the last decade, complex scientic
advances, globalization, and challenging new safety issues have combined
to multiply the responsibilities of the FDA. As this new report makes
clear, our expectations cannot exceed the resources we give FDA to
accomplish its mission. In this regard, more is denitely better, said
Mark McClellan, MD, former FDA commissioner and chairman of the new
Reagan-Udall Institute.
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
________________
____________________
__________________
_________________
14 C L E A N R O O MS J A N U A R Y 2 0 0 8
setting the standard
w w w . c l e a n r o o m s . c o m
IEST marches on to nanotech beat
IEST sets goals for new nanotechnology Recommended Practice
Working Group activities
By John R. Weaver II, Senior Member, IEST
T
he Institute of Environmental Sciences and Technology
(IEST) is taking a leading role in addressing the needs of the
important nanotechnology discipline through the formation
of relevant Recommended Practices. The IEST Nanotechnolo-
gies Standards and Practices (S&P) Committee has dened its scope as
follows: To take the lead in the development of Standards and Recom-
mended Practices and to establish related educational efforts in the eld
of nanotechnology by building on the established experience and expertise
of IESTs membership. In addition, the Nanotechnologies S&P Commit-
tee will strive to enhance IESTs participation in this eld by seeking out
experts outside of the IEST from business, academia and government.
Working Group 200 (WG-CC200) is developing an overview docu-
ment, Nanotechnologies Overview: Planning, Design, Construction, and
Operational Considerations for Facilities Engaged in Research or Pro-
duction at the Nanometer Scale. This work is well underway and should
be completed and ready for publication in 2008 as a Recommended
Practice/Guideline.
In addition, Working Group 205 (WG-CC205), Nanotechnology
Safety: Applying Prevention through Design Principles to Nanotechnol-
ogy Facilities has recently been formed and held its inaugural meeting
on November 14 at the IEST Fall Conference in Chicago, with a subse-
quent meeting planned for ESTECH 2008. The National Institute of Oc-
cupational Safety and Health (NIOSH), through the Centers for Disease
Control and Prevention, has indicated its interest in participating in this
Working Groups activities through a Memo of Understanding (MOU).
End users, vendors, and governmental and public participants are
encouraged to attend the nanotechnology working group meetings.
ESTECH 2008, the 54th annual technical meeting and exposition
of IEST, will be held May 47 at the Hilton Chicago/Indian Lakes Resort
in Bloomingdale (Northwest Suburban Chicago), IL. In addition to the
scores of presentations, tutorials, and working groups of interest and
importance to the design, test, and evaluation, product reliability, and
contamination control technical communities, a signicant portion of
the event will center on the burgeoning science of nanotechnology (see
ESTECH 2008: Focus on nanotechnology
Keynote
IEST is pleased to announce that E. Clayton Teague, PhD, will give the keynote
address at the Annual Awards and Membership Luncheon on Tuesday, May
6, 2008. Teague is director of the National Nanotechnology Coordination
Offce (NNCO), and previously served as chief of the Manufacturing
Metrology Division in the Manufacturing Engineering Laboratory of the
National Institute of Standards and Technology (NIST).
Teague also served as editor-in-chief of the journal Nanotechnology for
10 years and is currently a member of its editorial board. He received a BS
and an MS in physics from the Georgia Institute of Technology and a PhD in
physics from the University of North Texas. He has authored or co-authored
70 papers, has presented 50 invited talks in the technical felds described,
and has six patents jointly with colleagues. Teague has received the Gold
Medal, Silver Medal, and Allen V. Astin Measurement Science Award from
the Department of Commerce.
Nanotechnology track
In addition to the keynote address, immerse yourself in all things nano at
ESTECH 2008.
John Weaver, facilities manager of the Birck Nanotechnology Center
(BNC) at Purdue University, will give a full-day tutorial on nanotechnology
facility design on Monday, May 5. Nanotechnology working groups will
meet on Tuesday and Wednesday, May 6 and 7. A seminar (technical
session) on nanotechnology will take place on May 6 and will be chaired
by David S. Ensor, PhD, IEST Fellow and delegate to the U.S. Technical
Advisory Group (TAG) to ISO Technical Committee 229 Nanotechnologies.
The ESTECH nanotechnology track is sponsored by HDR Architecture, Inc.,
the architects of the BNC.
Birck Nanotechnology Center Tour
Concluding ESTECH 2008 on Thursday, May 8, will be an optional all-day tour
by motor coach departing from Hilton Chicago/Indian Lakes Resort to the Birck
Nanotechnology Center at Purdue University in West Lafayette, IN. The BNC
leverages advances in nanoscale science and engineering to create innovative
nanotechnologies addressing societal challenges and opportunities in com-
puting, communications, the environment, security, energy independence, and
health. In turn, the BNC exploits the accelerating progress in nanotechnology,
utilizing the most advanced nanoscale instrumentation to pursue answers to
fundamental questions in the life and physical sciences. The interplay between
these two complementary arcs of inquiry fosters a stimulating interdisciplinary
environment for discovery well into the 21st century.
Watch for information about ESTECH 2008 at www.iest.org.
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
__________________
Require Demanding Control.
Precision 0.5% Full Scale Accuracy in Ranges Down to 0.25 w.c.
Selectable Engineering Units in Pressure, Velocity and Flow
2 SPDT Relays, 4-20 mA Output & RS-485 Communications
Available Digihelic
March26-28, 2008
Pennsylvania Convention Center
Philadelphia, PA
Priority Code: AD16
Produced and managed by: Sponsored by: Media sponsors:
Nows the time to register for INTERPHEX! Visit
www.interphex.com now for FREE show admission.
Questions? Call 1.888.334.8704.
Featuring co-locations with:
INDIA MEXICO 04, 2008 PUERTO RICO 02, 2008 SINGAPORE USA 03, 2008 JAPAN CHINA
Media supporter:
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
Figure 1. Active RABS pressure zone. Photo courtesy of Bosch Packaging Technology, Valicare Division.
24 C L E A N R O O MS J A N U A R Y 2 0 0 8
barrier systems
w w w . c l e a n r o o m s . c o m
Using RABS and isolators in
pharmaceutical applications
Barrier technology offers clean spaces for pharmaceutical
flling and packaging, as well as protection for operators
By Jack Lysfjord, Lysfjord Consulting LLC
B
arrier technology is designed to replace the use of con-
ventional ISO 5 cleanrooms in pharmaceutical lling and
packaging (i.e., ampoules, vials, cartridges, and pre-lled
syringes). The goal of barrier systems, isolators and restrict-
ed barrier access systems (RABS), is to segregate people from the prod-
uct, ensuring that pharmaceuticals are not exposed to viable organisms
or particulate contamination. When dealing with highly potent formula-
tions, these systems can protect operators as well.
Isolators are enclosed, usually positively pressurized units with
high efciency particulate air (HEPA) lters supplying ISO 5 airow in
a unidirectional manner to the interior. Air is typically recirculated by
returning it to the air handlers through sealed ductwork. Cleaning can
be manual or automated (clean-in-place). Bio-decontamination occurs
through an automated cycle typically using vaporized hydrogen peroxide.
Access to an isolator is through glove ports
and sterile transfer systems. Isolators can be
located in an ISO 8 or better environment.
RABS also process in an ISO 5 environ-
ment, with varying degrees of contact with the
surrounding room, which is generally clas-
sied ISO 7 or better. Bio-decontamination
is performed manually in a RABS. Although
doors can be opened, this is a rare occurrence,
after which the system must be appropriately
sanitized, a necessary line clearance per-
formed, and the intervention documented.
Key differences between
RABS and isolators
Compared to isolators, RABS can allow for
faster start-up and ease of changeover, and,
accepting certain restrictions, offer increased
operational exibility and reduced validation
and revalidation expenditure. Contract manu-
facturers tend to gravitate to RABS because of
speed of changeover.
RABS air handling units operate in a
fashion similar to laminar ow hoods (LFHs)
in that they are fed clean air from fan units through HEPA lters and
air vents from the unit into the RABS. Air exit is through openings to the
room at a low level on the equipment. RABS provide separation by the
barrier and by positive airow. Isolator air handling requirements are
more complicated because air is recirculated, necessitating return fans
and ductwork. In order to maintain positive pressure, the air handling
unit must be leak tight.
There are also differences in cleaning and bio-decontamination for
RABS and isolators as mentioned previously. Cleaning must occur rst,
removing stoppers, broken glass, and spilled product 9the dirt), and then
bio-decontamination can occur. RABS are typically cleaned manually,
or a CIP system can be used after manual clean-up of commodities.
Isolators are bio-decontaminated through an automatic sequence
by injecting vaporized hydrogen peroxide (VHP). Validation of the
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
__________________
Shortridge Instruments, Inc.
7855 E. REDFIELD ROAD / SCOTTSDALE, ARIZONA 85260-3430
TELEPHONE (480) 991-6744 / FAX (480) 443-1267
WWW.SHORTRIDGE.COM
Figure 2. Aseptic powder flling in a passive RABS. Photo courtesy of Bosch Packaging Technology, Valicare
Division.
barrier systems
C L E A N R O O MS J A N U A R Y 2 0 0 8 25 w w w . c l e a n r o o m s . c o m
manual cleaning is more challenging than the
automated cleaning cycle of a CIP system.
Environmental monitoring is necessary to
ensure the integrity of the ISO 5 environment
in both systems. Monitoring in isolator systems
can only be achieved though built-in sampling
ports or sterile transfer of sampling devices.
The environmental monitoring requirements
of an isolator system are therefore key design
considerations. These same methods can be
employed in RABS, but there is also the option
of using portable sampling devices inserted
into the oor-level air exit openings.
Responding to current trends
in the pharmaceutical market
There are a number of trends within the
pharmaceutical industry that will make RABS
and isolators critical components of any
successful packaging and processing operation.
Biotechnology is having a big impact
and reshaping the processing demands on
pharmaceutical rms. Live vaccines, large
molecules, and protein-based drugs are
increasingly the trend and require highly aseptic
conditions. These products are preservative free
and are usually a growth medium; therefore,
they are easily contaminated.
Toxic, cytotoxic, and otherwise highly po-
tent applicationsimmunosuppressive cancer
drugs are a key examplealso demand strin-
gent barrier technology to protect operators.
Broadly speaking, there is a trend toward
continued on page 26
Environmental
monitoring is
necessary to ensure
the integrity of the
ISO 5 environment in
both systems.
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
__________________
__________________
Figure 3. FLC vial flling in a passive RABS. Photo courtesy of Bosch Packaging
Technology, Valicare Division.
w w w . c l e a n r o o m s . c o m 26 C L E A N R O O MS J A N U A R Y 2 0 0 8
barrier systems
smaller volume, higher value pharmaceuticals. Manufacturing in high-
throughput, mass production systems that produce millions of dosages
is declining and the ultimate cost-effectiveness of constructing a large
ISO 5 cleanroom facility must be addressed in the long term.
Smaller systems that meet high regulatory standards and can be
customized to small product runs are an increasingly attractive option.
More compact, adaptable lines allow for exible congurations and en-
able manufacturers to respond rapidly to changes in market demand.
Isolators are ideal for smaller facilities that employ exible,
reduced-footprint systems. Compared to conventional cleanroom
processing, isolators offer pharmaceutical rms signicant capital
and operational cost savings. Furthermore, with a smaller isolator sys-
tem there are minimized gowning costs and reduced labor and mainte-
nance expenses.
Regulatory issues to consider
The critical regulatory concern for barrier systems is so-called open
door interventions in a RABS. Such interventions introduce undesirable
variables into the operation and potentially compromise the aseptic envi-
ronment and so should be avoided or minimized.
However, when such interventions are unavoidable, appropri-
ate measures must be taken to ensure the aseptic environment is
maintained. Open door interventions inevitably prompt heightened
regulatory scrutiny, demanding particularly scrupulous observance of
standard operating procedures (SOPs).
When open door interventions are necessary, an ISO 5 vertical
unidirectional airow system outside of the RABS reduces risk of a
breach in ISO 5 conditions and further safeguards the aseptic integ-
rity of the system. Each intervention that requires opening of a door of
the RABS is regarded and documented as an intervention. Interlocked
RABS doors facilitate control and documentation. Following an open
door intervention, appropriate line clearance and disinfection com-
mensurate with the nature of the incident are required.
Challenges in implementing a RABS or isolator
Many companies forget the systems aspect of RABS and isolators. For
successful implementation of these technologies, operators, mainte-
nance personnel, and engineers must take an expansive, holistic view
of their system, ensuring that it is integrated into its surrounding en-
vironment and instituting the appropriate maintenance and oversight
regimes.
This includes appropriate surrounding building and room design,
including HVAC and air handling systems. Proper disposal systems for
bio-decontamination waste, both within the building and in relation to
the exterior natural environment, are also key considerations. Drainage
systems and building HVAC should also be taken into account. Building
system utilities can impact isolator pressure control schemes.
Management oversight is indispensable. Proper gowning pro-
cedure, adequate training in current good manufacturing practice
(cGMP), SOPs for interventions, and documentation protocols must be
instituted, rigorously executed, and consistently enforced. Continuous
system monitoring is also a must.
A RABS or isolator system should be understood not merely as a
discrete piece of a larger manufacturing process but as deeply integrated
with every other aspect of an operation. The line itself must be well
integrated. Moreover, a holistic view encompassing all of these exterior
concerns will ensure the successful implementation of a RABS or isolator
system. Integration is easiest through the use of experienced vendors,
especially those that can produce many components of the system. More
vendors means more customer project management and more tasks to
juggle, which can lead to potential project risk.
Jack Lysfjord is principal consultant for Lysfjord Consulting LLC. He previously served
as vice president of consulting for Valicare, a division of Bosch Packaging Technology
(www.boschpackaging.com).
continued from page 25
Smaller systems that meet
high regulatory standards
and can be customized to
small products runs are an
increasingly attractive option.
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
__________________
1IBSNBDFVUJDBM
HSBEFXBUFSTZTUFNT
J|e oatt|e aa|rst
res|start oacter|a
0|oos|r part|c|e
sarp||r po|rts
For more information on print or digital media advertising or exhibiting
opportunities at CleanRooms shows, contact Barbara Kovalchek,
National Sales Manager, at 603-891-9296 or barbarak@pennwell.com.
With 25,500
1
BPA-qualied, international subscribers, CleanRooms magazine is the
undisputed leader in providing contamination control technology information and
expertise to contaminaton control professionals. Providing in-depth news, comprehensive
staff-researched reports, authoritative contributed technical articles, extensive new
products coverage, and insightful columns and commentary, CleanRooms reaches
contamination control professionals in the semiconductor, bio/pharmaceutical, food
processing, compounding pharmacy, cosmetics, hospital hygiene, and all other industries
requiring clean or ultraclean manufacturing environments and processes.
And, together with its complete multimedia family of products and services including
International Conferences & Exhibitions, twice-monthly eNewsletters, information-packed
Website, and interactive, on-line Webcast presentations, CleanRooms is unsurpassed in
its educational and informational service to the entire contamination control community,
worldwide.
For a FREE subscription, visit www.cr-subscribe.com
1
Source: June 2007 BPA Worldwide Statement.
The#
1
resource in the world
for Contamination Control Technology Information.
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
28 C L E A N R O O MS J A N U A R Y 2 0 0 8
planetary protection
w w w . c l e a n r o o m s . c o m
New detection methods reinforce
protocols for planetary protection
NASA planetary protection programs charged with keeping
biocontamination out of space
By Patrick Hogue, Johns Hopkins University, Applied Physics Laboratory
N
ational Aeronautics and Space Administration (NASA)
missions to solar system bodies with the potential to sus-
tain life, or that could potentially contain life in a fun-
damental evolutionary state, have stringent requirements
on the maximum spore count permissible on spacecraft surfaces; and
these levels are likely to become lower as cleanroom protocols become
more efcient. Several promising technologies can help contractors
reduce spore counts to acceptable levels, provide for the rapid deter-
mination of microorganisms, and determine the genomic inventory of
spacecraft microorganisms.
Establishing planetary protection policy
The need for planetary protection, and protection of Earth by sample
return missions, was recognized at the dawn of the Space Age through
the Committee on Space Research (COSPAR).
1
Article IX of the Outer
Space Treaty of 1967 states, in part, ...parties to the Treaty shall
pursue studies of outer space including the Moon and other celestial
bodies, and conduct exploration of them so as to avoid their harmful
contamination and also adverse changes in the environment of the
Earth resulting from the introduction of extraterrestrial matter and,
where necessary, shall adopt appropriate measures for this purpose.
2
NASA Policy Directive (NPD) 8020.7 establishes NASA policy for
implementing planetary protection (PP), which includes protection
of planetary bodies for future exploration and of Earth from
extraterrestrial sources of contamination. Depending upon the target,
implementation may range from obtaining a letter from NASA approving
mission design as adequate planetary protection (e.g., New Horizons
Pluto y-by, category II) all the way to full implementation (e.g., Mars
sample return, category V). For samples returned from a solar system
body with the potential for life (e.g., Europa) mission design must
break the chain of contact; furthermore, for un-sterilized samples
returned to Earth, a program of life detection and biohazard testing
or a proven sterilization process shall be undertaken as an absolute
precondition for the controlled distribution of any portion of the
sample.
3
Depending upon the nature of samples returned to Earth
quarantine up to Biosafety Level (BSL) 4 may be required.
In reaching these decisions, NASA seeks the opinion of scientic
advisory groups such as the Space Studies Board of the National
Academy of Sciences. NASA Procedural Requirement (NPR) 8020.12
delineates a uniform set of planetary protection requirements for all
NASA robotic extraterrestrial missions and references NPR 5340.1,
which provides a uniform set of procedures for performing microbial
assays for enumerating bioburden levels of spacecraft and facilities
used to assemble, test, and launch spacecraft with planetary protection
requirements (it is written primarily for use by microbiologists). This
year, NPR 5340.1 will re-release as NASA HDBK 6022, which will not set
requirements but will list approved protocols. The two Viking Landers,
which received dry heat sterilization at 125C, are considered the gold
standard for planetary protection.
Detailed microbial burden requirements
NPR 8020.12 allows alternatives to 125C dry heat sterilization
provided that procedures and quality controls are approved by the NASA
Planetary Protection Ofcer (PPO). These methods are then spelled
out in the approved PP plan. Flight hardware drawings may call for
these unique microbial reduction methods by citing their specication
numbers. Microbial barriers may be used to prevent recontamination
of previously sterilized areas; a pressure of at least 1,244 Pa (5 inches
H
2
O) is considered satisfactory to prevent the entry of microorganisms.
High efciency particulate air (HEPA) lters (99.97 percent efcient
for 0.3 m) are also considered effective microbial barriers. NASA
requires that spacecraft assembly occur in a cleanroom meeting ISO
class 8 (Fed. Std. 209E Class 100,000) as a minimum.
For a Mars Lander mission, the maximum spore count is 300,000
for the entire spacecraft (or <300 bacterial spores/m
2
); all other tar-
gets still have a probabalistic requirement. The quantity of 300,000
spores per total spacecraft surface area applies to non-special regions
of Mars (most of the surface); the total allowed, including organisms
inside hardware (e.g., encapsulated in potting) is 500,000. The Vikings,
and spacecraft accessing special regions or looking for life, met/must
meet 300,000 and then reduce the surface bioburden by 10,000 with
dry heat sterilizationmeaning no more than 30 viable spores total
on the surface. Alternatives to dry heat are discussed later. Based upon
Viking experience, NPR 8020.12 assumes spore content as shown in the
table. Possible reduction methods are noted and also will be explained
in another section.
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
__________________
Gloveboxes
Acrylic
& Other
Plastics
BioSafe
Aseptic
Chambers
Hundreds of standard enclosures
Stainless steel Dissipative PVC Polycarbonate
Polypropylene Acrylic More!
Mix and match standard process controls for
Temp. (-40 to 300C) Vacuum Fume removal
High/low humidity Particle filtration Static control
Process gas generation & mixing
To order: 714-578-6000
Fax: 714-578-6020
C L E A N R O O MS J A N U A R Y 2 0 0 8 29 w w w . c l e a n r o o m s . c o m
Origin of spores Requirement Possible reduction
Electronic parts 3150/cm
3
Burn-in, radiation screening
Other non-metallics 130/cm
3
Dry heat sterilization in bulk
Class 10k highly controlled 50/m
2
Preferred for PP mission
Class 10k normal control 500/m
2
Described in Reduction section
Class 100k highly controlled 1,000/m
2
Described in Reduction section
Class 100k normal 10,000/m
2
Described in Reduction section
Uncontrolled manufacturing 100,000/m
2
Clean tent; upgrade discipline
Assessing microorganism levels
Most aerospace cleanrooms have unknown mi-
crobial deposition rates and surface microbial
populations and usually do not have a micro-
biology laboratory readily available. While a
proper microbiology laboratory is being cre-
ated to implement NPR 5340.1, PP programs
may choose to get a head start in making their
cleanrooms as aseptic as possible. To this end an
interim laboratory can be constructed, using a
Class 100 (ISO class 5) ow bench with table-
top incubator. Initial assays of the cleanrooms
(including thermal vacuum chambers, acoustic,
and vibration facilities) and associated equip-
ment can be performed using commercially
available settling plates (to capture microbial
fall-out) and contact plates (to assay cleanroom
surfaces) based on Tryptic soy agar (TSA). These
procedures are designed primarily for the detec-
tion and enumeration of heterotrophic, meso-
philic, aerobic, and anaerobic microorganisms;
consult NPR 5340.1 for details. Microorganisms
likely to survive space and planetary environ-
ments are halophiles, certain Bacillus species
and extremophiles.
It is recommended that these initial as-
sessment techniques, and others that may be
recommended by local microbiology or phar-
maceutical laboratory suppliers, be included in
the PP plan and that they, along with the full
NPR 5340.1 implementation plan, be approved
by the NASA PP ofcer.
During this initial phase of assessing
cleanrooms for fall-out and hot spots, a por-
table aerosol particle counter may be used to
scan HEPA lter outlets for leaks and any re-
pairs or replacements made before the start-
up of PP program work. A rotary centrifugal
impactor equipped with TSA strips can be used
to validate the biological effectiveness of each
HEPA outlet in the overall cleanroom. An al-
ternative would be to place one settling plate
for each HEPA outlet at a distance of approxi-
mately 1 m; of course, timely retrieval and in-
cubation are essential.
If the trial-and-error methods described
previously are not satisfactory for character-
izing the cleanroom, then recourse can be
made to real-time microbial particle detection
technology. Most of these are based upon the
uorescence of energetic metabolic chemicals
(e.g., adenosine triphosphate, or ATP, riboa-
vin) induced by ultraviolet light
4,5
, although continued on page 30
planetary protection
immunoafnity-based phosphorescent sensors
are being developed for detection of bacterial
spores.
6
Recently individual bacterial cells have
been detected using Raman spectroscopy.
7
Spot-checks of surfaces can be
accomplished using commercially available
portable systems based on the luciferin-
luciferase reaction produced in the common
rey. These methods usually consist of
reagent-dampened sterile swabs that lyse
(chemically open) living cells and then react
with ATP, the energy currency of living cells, to
produce a brightly colored species that can be
quantitatively measured with a luminometer.
This kind of spot-check was recently performed
on the Space Station surfaces using a NASA-
developed variant called LOCAD-PTS, which is
expected to become an approved protocol in
NASA HDBK 6022 (see Fig. 1).
8
Rapid microbial detection using lter-based
media with ATP bioluminescence enumeration
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
__________________
Figure 1. Astronaut Suni Williams, Expedition 14/15 fight engineer, works with
the Lab-on-a-Chip Application DevelopmentPortable Test System (LOCAD-
PTS). Williams is placing the sample mixed with water from the swabbing unit
into the LOCAD-PTS cartridge. Photos courtesy of NASA.
8
30 C L E A N R O O MS J A N U A R Y 2 0 0 8
planetary protection
w w w . c l e a n r o o m s . c o m
continued from page 29
by a CCD camera equipped with a microchannel plate photomultiplier
can reduce assay times from 72 hours to 5 hours or less as demonstrated
by NASA/JPL.
9
A recent addition to this technology is the use of a 16-base
RNA probe that can be used to identify specic organisms after the non-
specic uorescence enumeration measurement is accomplished.
10
Implementation of NPR 5340.1
The cost of a fully equipped microbiology laboratory to support a
spacecraft program with full PP requirementsa Mars Lander, for
exampleis estimated to be $50,000 and will require at least two
technicians, preferably three, to provide 24/7 coverage.
11
The cost
associated with PP implementation is estimated to have added 2 months
to an 18-month assembly, test, and launch operations program for Mars
Polar Lander (MPL) and required 1,200 assays.
12
Viking program PP cost
was 10 percent or about $7 million.
13
A successful PP implementation
hinges on the following:
1. Careful and thorough integration of PP into all aspects of the
program
2. Management buy-in and support of the PP engineer
3. Universal personnel training (including purchasing and support
groups)
4. Pre-planned bio-assay database that parallels the assembly ow
5. Lessons learned from the MPL program:
eNewsletters
Your total source for contamination
controldelivered to your inbox!
www.cleanrooms.com
CLEANROOM SERVICES
Janitorial Disinfect Supercleans
Certification Microbial Testing
Training Monitors Audits
Build Clean Protocol Supplies
Guaranteed Effortless Control !!!
WORLDWIDE
www.advcleanroom.com
Sales@advcleanroom.com
1-800-649-4625
w w w . c l e a n r o o m s . c o m
resource marketplace
J A N U A R Y 2 0 0 8 C L E A N R O O MS 47
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
________
__________________
48 C L E A N R O O MS J A N U A R Y 2 0 0 8
Calendar
To announce your organizations upcoming conferences and meetings (date, location, and information), email: carriem@pennwell.com.
w w w . c l e a n r o o m s . c o m
FEBRUARY 58
The Aseptic Filling Conference 2008. Danubius
Hotel, Regents Park, London, U.K. For more
information: www.iir-events.com
FEBRUARY 1415
INTERPHEX Puerto Rico 2008. Puerto Rico
Convention Center, San Juan. For more
information: www.interphexpuertorico.com
MARCH 17
PITTCON 2008, 59th Pittsburgh Conference on
Analytical Chemistry and Applied Spectroscopy.
Ernest N. Morial Convention Center, New Orleans,
LA. For more information: www.pittcon.org
MARCH 1113
CleanRooms Europe 2008 Conference & Exhibi-
tion. Neue Messe Stttgart, Stttgart, Germany.
For more information: www.cleanroomseurope.
com
MARCH 1719
Food Safety & Security Summit 2008. Washington
DC Convention Center, Washington, DC. For more
information: www.foodsafetysummit.com
MARCH 1820
SEMICON China 2008. Shanghai New
International Expo Center, Shanghai, China. For
more information or to register: www.semi.org
MARCH 2529
Semiconductor Environmental Safety & Health
Association (SESHA) 30th Annual International
High Technology ESH Symposium & Exposition.
Double Tree Hotel, Portland, OR. For more
information: www.semiconductorsafety.org
MARCH 2628
INTERPHEX 2008. Pennsylvania Convention
Center, Philadelphia, PA. For more information:
www.interphex.com
MARCH 2628
PharmaMedDevice Conference and Exhibition.
Pennsylvania Convention Center, Philadelphia, PA.
For more information: www.pharmameddevice.
com
MARCH 31APRIL 2
2008 Surface Preparation and Cleaning
Conference, Emerging Technologies in
Semiconductor Surface Preparation, sponsored
by SEMATECH. Sheraton Austin Hotel, Austin, TX.
For more information: www.sematech.org
APRIL 69
Food Automation & Manufacturing Conference
and Expo 2008. Sheraton Sand Key, Clearwater
Beach, FL. For more information: www.bnpevents.
com/FE/FAM/
APRIL 1215
Controlled Environment Testing Association
(CETA) 16th Annual Meeting. Crown Plaza Hotel,
San Antonio, TX. For more information: www.
cetainternational.org
APRIL 1418
Parenteral Drug Association (PDA) Annual
Meeting. The Broadmoor, Colorado Springs, CO.
For more information: www.pda.org
APRIL 2122
ESD Device/Design Seminar. ESD Association
Headquarters, Rome, NY. For more information:
www.esda.org
APRIL 2125
Hannover Fair/Microtechnology 2008. Hannover
Messegelnde, Hannover, Germany. For more
information: www.ivam.de
MAY 47
ESTECH 2008, 54th IEST Annual Technical
Meeting. Hilton Bloomingdale Indian Lakes
Resort, Bloomingdale, IL. For more information:
www.iest.org
MAY 57
SEMICON Singapore 2008. Suntec Singapore
International Convention & Exhibition Center,
Singapore. For more information: www.semi.org
MAY 57
19th Annual IEEE/SEMI Advanced Semiconductor
Manufacturing Conference (ASMC). Boston, MA.
For more information: www.semi.org
MAY 1215
2nd Annual International Electrostatic Discharge
Workshop (IEW). Port DAlbret, France. For more
information: www.esda.org
MAY 1821
The ConFab, semiconductor conference and
exhibition. Loews Las Vegas Resort, Las Vegas, NV.
For more information: www.theconfab.com
MAY 2829
International Pharmaceutical Regulatory
and Compliance Congress, sponsored by the
Pharmaceutical Compliance Forum. Paris Marriott
Rive Gauche Hotel and Convention Center, Paris,
France. For more information: www.InternationalP
harmaCongress.com
JUNE 15
Nano Science and Technology Institute (NSTI)
Nanotech 2008. Hynes Convention Center,
Boston, MA. For more information: www.nsti.org
JUNE 15
American Society for Microbiology (ASM), 108th
General Meeting, Trade Show and Conference.
Boston Convention and Exhibition Center, Boston,
MA. For more information: www.gm.asm.org
JUNE 25
Medical Design & Manufacturing (MD&M) East.
Jacob K. Javits Convention Center, New York, NY.
For more information: www.mdmeast.com
JUNE 1518
21st international Symposium, Exhibit, & Work-
shops on Preparative/Process Chromatography.
Doubletree San Jose Hotel, San Jose, CA. For
more information: www.prepsymposium.org
JUNE 1720
BIO International Convention 2008. San Diego
Convention Center, San Diego, CA. For more
information: www.bio2008.org
JUNE 2325
2008 AAPS National Biotechnology Conference.
Metro Toronto Convention Centre, Toronto,
Ontario, Canada. For more information: www.
aapspharmaceutica.com
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
___
______________
__
__
___________ ___
__________________
MAY 1821, 2008
LOEWS LAKE LAS VEGAS RESORT, LAS VEGAS, NEVADA
The Meeting for Key Decision Makers on Semiconductor Fabrication
WWW.THECONFAB.COM
Loews Lake Las Vegas Resort in Las Vegas. An ideal destination for
The ConFab offering flexible meeting and function space in an intimate
and relaxed setting.
Semiconductor Equipment and Material Suppliers: If you would like
more information on our list of participants for the 2007 event or want
to become a sponsor of The ConFab in 2008, please call Jay Novack at
(603) 891-9186, or email jayn@pennwell.com.
Semiconductor Device Manufacturing Executives: If you are a senior
level decision maker and would like to attend our event, please email
Luba Hrynyk at lubah@pennwell.com, or visit us at www.theconfab.com
to find out how to qualify as our VIP guest.
WHAT YOUR COLLEAGUES SAY
ABOUT THE CONFAB
The ConFab is still one of the best conferences out there and its
arguably the best place for suppliers to network with chip makers in
the world it was one of the best third-year conferences Ive been to,
which shows PennWell still has a winning formula As for the
presentations, they were generally excellent and the topics were superb.
G. DAN HUTCHESON, CEO OF VLSI RESEARCH, INC.
AND PUBLISHER OF THE CHIP INSIDER (JUNE 15, 2007)
Keeps getting better each year, the change of venue was very positive.
DIRECTOR 300MM FAB OPERATIONS ALBANY NANOTECH,
IBM
Excellent format and well worth the time.
VP, AMKOR TECHNOLOGY
The ConFab continues to differentiate itself from other conferences by
providing opportunities to meet with top executives and to engage in
open discussions within an informal setting. The event is well organized
and the conference is conducive to attracting senior level executives.
Overall, a great conference.
VICE PRESIDENT, TECHNICAL SALES AND MARKETING,
NIKON PRECISION INC.
The entire conference was most informative and the networking was
great. We set up a number of follow-up meetings in our facility as a
result of our discussions at The ConFab. We also wish to thank you and
your team for a flawless execution and logistic support to make our
whole experience so much more enjoyable.
COO AND CFO, CSMC TECHNOLOGIES CORPORATION
THE CONFERENCE:
Managing the New Economics
of Semiconductor Manufacturing
Hear industry experts on critical manufacturing issues and gain practical
information that can be applied in fabs and manufacturing strategies.
THE MEETINGS:
Private Boardroom Meetings with Leading Equipment
& Material Suppliers & Device Manufacturers
Participate in private executive meetings with material and equipment
suppliers and device manufacturers. Build alliances with new and
current business partners.
THE NETWORKING:
Peer-to-Peer Collaboration
Join your semiconductor manufacturing peers, suppliers and industry
thought leaders.
2005
THE CONFAB IS A HIT!
2006
THE CONFAB
A SECOND GREAT YEAR!
2007
ONE OF THE BEST
THIRD-YEAR CONFERENCES
PENNWELLS WINNING FORMULA!
Meeting theChallenges.Building the Future.
OWNED & PRODUCED BY: MEDIA SPONSORS:
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms
___________________
The Ultimate Pass-Through
for Aseptic Environments!
Seamless Unique design eliminates cracks, corners and
other contaminant traps!
Lipless Easy material transfer with no clearance obstruction
Easy to Clean Ultra-smooth internal surfaces
Easy to Sterilize 304/316 SS; removable doors can be
steam sterilized
Double-Wall, Sealed Construction adds rigidity
and houses interlock and utilities
BioSafe Pass-Throughs
To order: 714-578-6000
Fax: 714-578-6020
and house i t ss innt
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
Previous Page Contents Zoom In Zoom Out Front Cover Search Issue Next Page M S a
G
F
CleanRooms
CleanRooms